<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1130-0108</journal-id>
<journal-title><![CDATA[Revista Española de Enfermedades Digestivas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. esp. enferm. dig.]]></abbrev-journal-title>
<issn>1130-0108</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Española de Patología Digestiva]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1130-01082018000800003</article-id>
<article-id pub-id-type="doi">10.17235/reed.2018.5435/2017</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Análisis retrospectivo en pacientes con cáncer de vesícula biliar: tratamiento quirúrgico y supervivencia en función del estadio tumoral]]></article-title>
<article-title xml:lang="en"><![CDATA[A retrospective analysis of patients with gallbladder cancer: surgical treatment and survival according to tumor stage]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Justo]]></surname>
<given-names><![CDATA[Iago]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Marcacuzco]]></surname>
<given-names><![CDATA[Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nutu]]></surname>
<given-names><![CDATA[Oana-Anisa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Manrique]]></surname>
<given-names><![CDATA[Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Calvo]]></surname>
<given-names><![CDATA[Jorge]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Caso]]></surname>
<given-names><![CDATA[Óscar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cambra]]></surname>
<given-names><![CDATA[Félix]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García-Sesma]]></surname>
<given-names><![CDATA[Álvaro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jiménez-Romero]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Complutense de Madrid Departamento de Cirugía. Facultad de Medicina Unidad de Cirugía Hepato-Bilio-Pancreática y Trasplante de Órganos Abdominales. Hospital Universitario 12 de Octubre]]></institution>
<addr-line><![CDATA[Madrid ]]></addr-line>
<country>Spain</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2018</year>
</pub-date>
<volume>110</volume>
<numero>8</numero>
<fpage>485</fpage>
<lpage>492</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1130-01082018000800003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1130-01082018000800003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1130-01082018000800003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  el cáncer de vesícula biliar es la neoplasia más frecuente de vías biliares y el sexto de los tumores del aparato digestivo, presentando un pronóstico ominoso, con una supervivencia a cinco años alrededor del 5%. Suele diagnosticarse de forma tardía y la única posibilidad de curación es la resección quirúrgica.  Métodos:  se realizó un estudio retrospectivo en el cual fueron analizados 92 pacientes (64 mujeres y 28 hombres) diagnosticados por anatomía patológica con cáncer de vesícula entre enero de 2000 y enero de 2016.  Resultados:  la edad media de la serie fue 72 ± 11 años. Los síntomas de los pacientes al ingreso fueron: dolor abdominal (78%), anorexia (77%), náuseas (76%) e ictericia (45%). La cirugía se indicó en los 92 (100%) pacientes y se realizó una resección con intención curativa en 59 (64%) de ellos. Entre los procedimientos quirúrgicos realizados en la cirugía inicial, la colecistectomía simple se efectuó en 69 (75%) y la colecistectomía extendida, en once (11%) pacientes. La cirugía de rescate se realizó en 15 pacientes después del hallazgo tumoral en la pieza de colecistectomía, realizando una resección curativa R0 en diez pacientes. Además, la terapia adyuvante se utilizó en 30 (33%) pacientes. La mediana de la supervivencia de nuestra serie fue de 12,5 meses, con supervivencias del 57%, 30% y 20% a uno, tres y cinco años, respectivamente.  Conclusión:  en conclusión, en todos los pacientes se debe plantear el tratamiento quirúrgico con resección tumoral completa, siempre y cuando la situación clínica del paciente lo permita.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  gallbladder cancer is the most common biliary neoplasm and the sixth most common tumor of the digestive system. The disease has an ominous prognosis, with a 5-year survival rate of approximately 5%. It is usually diagnosed late and surgical resection is the only potential cure.  Methods:  a retrospective study was carried out in 92 patients with a pathological diagnosis of gallbladder cancer from January 2000 to January 2016.  Results:  the mean age of cases was 72 ± 11 years; 64 subjects were females and 28 were males. Symptoms at admission included abdominal pain (78%), anorexia (77%), nausea (76%) and jaundice (45%). Surgery was indicated in 92 (100%) patients and 59 (64%) underwent a curative/intent resection. The initial surgical procedures included simple cholecystectomy in 69 (75%) cases and extended cholecystectomy in eleven (11%) subjects. Rescue surgery was performed in 15 patients with tumor tissue in the cholecystectomy specimen; ten individuals underwent an R0 curative resection. Adjuvant therapy was administered in 30 (33%) patients. The median survival in our series was 12.5 months, with survival rates of 57%, 30% and 20% at one, three and five years, respectively.  Conclusion:  to conclude, surgical treatment with a complete tumor resection should be considered for all patients, provided that their clinical status allows it.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cáncer de vesícula]]></kwd>
<kwd lng="es"><![CDATA[Colecistectomía simple]]></kwd>
<kwd lng="es"><![CDATA[Colecistectomía extendida]]></kwd>
<kwd lng="es"><![CDATA[Cáncer de vesícula incidental]]></kwd>
<kwd lng="en"><![CDATA[Gallbladder cancer]]></kwd>
<kwd lng="en"><![CDATA[Simple cholecystectomy]]></kwd>
<kwd lng="en"><![CDATA[Extended cholecystectomy]]></kwd>
<kwd lng="en"><![CDATA[Incidental gallbladder cancer]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cancer statistics, 2017]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Siegel]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[KD]]></given-names>
</name>
<name>
<surname><![CDATA[Jemal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[CA Cancer J Clin]]></source>
<year>2017</year>
<volume>67</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>7-30</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Gallbladder cancer epidemiology and outcome]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hundal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Schaffer]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Epidemiol]]></source>
<year>2014</year>
<volume>6</volume>
<page-range>99-109</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="">
<collab>American Cancer Society</collab>
<source><![CDATA[Cancer Facts &amp; Figures]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Gallbladder cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wernberg]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Lucarelli]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
</person-group>
<source><![CDATA[Surg Clin North Am]]></source>
<year>2014</year>
<volume>94</volume>
<page-range>342-60</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Gallbladder cancer (GBC) 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duffy]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Capanu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abou-Alfa]]></surname>
<given-names><![CDATA[GK]]></given-names>
</name>
</person-group>
<source><![CDATA[J Surg Oncol]]></source>
<year>2008</year>
<volume>98</volume>
<page-range>485-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Incidental gallbladder cancer by the AFC-GBC Study Group]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuks]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Regimbeau]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Le Treut]]></surname>
<given-names><![CDATA[YP]]></given-names>
</name>
</person-group>
<source><![CDATA[World J Surg]]></source>
<year>2011</year>
<volume>35</volume>
<page-range>1887-97</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Incidental gallbladder cancer at cholecystectomy when should the surgeon be suspicious?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pitt]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Jin]]></surname>
<given-names><![CDATA[LX]]></given-names>
</name>
<name>
<surname><![CDATA[Hall]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Surg]]></source>
<year>2014</year>
<volume>260</volume>
<page-range>128-33</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy a systematic review and meta-analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[World J Gastroenterol]]></source>
<year>2015</year>
<volume>21</volume>
<page-range>1315-23</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Incidental gallbladder cancer residual cancer discovered at oncologic extended resection determines outcome. A report from high- and low-incidence countries]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vinuela]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vega]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Yamashita]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Surg Oncol]]></source>
<year>2017</year>
<volume>24</volume>
<page-range>2334-43</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The American Joint Committee on cancer the 7th edition of the AJCC cancer stating manual and the future of TNM]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Edge]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Compton]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Surg Oncol]]></source>
<year>2010</year>
<volume>17</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1471-4</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Gallbladder cancer worldwide geographical distribution and risk factors]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Randi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Franceschi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[La Vecchia]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Cancer]]></source>
<year>2006</year>
<volume>118</volume>
<page-range>1591-602</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Gallbladder carcinoma prognostic factors and therapeutic options]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goetze]]></surname>
<given-names><![CDATA[TO]]></given-names>
</name>
</person-group>
<source><![CDATA[World J Gastroenterol]]></source>
<year>2015</year>
<volume>21</volume>
<numero>43</numero>
<issue>43</issue>
<page-range>12211-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Carcinoma of the gallbladder]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Misra]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chaturvedi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Misra]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet Oncol]]></source>
<year>2003</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>167-76</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evidence-based gallbladder cancer staging changing cancer staging by analysis of data from the National Cancer Database]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fong]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wagman]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gonen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Surg]]></source>
<year>2006</year>
<volume>243</volume>
<page-range>767-71</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Actualización del diagnóstico y el tratamiento del cáncer de vesícula biliar]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Suárez]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Santoyo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Cir Esp]]></source>
<year>2002</year>
<volume>71</volume>
<page-range>102-11</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[YF]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[XH]]></given-names>
</name>
</person-group>
<source><![CDATA[World J Gastroenterol]]></source>
<year>2014</year>
<volume>20</volume>
<numero>14</numero>
<issue>14</issue>
<page-range>4085-92</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Gallbladder cancer expert consensus statement]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aloia]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Járufe]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Javle]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[HPB (Oxford)]]></source>
<year>2015</year>
<volume>17</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>681-90</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The time of diagnosis impacts surgical management but not the outcome of patients with gallbladder carcinoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Löhe]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Meimarakis]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Schauer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur J Med Res]]></source>
<year>2009</year>
<volume>14</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>345-51</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Systematic review on the surgical treatment for T1 gallbladder cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Jang]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[LIM]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
</person-group>
<source><![CDATA[World J Gastroenterol]]></source>
<year>2011</year>
<volume>17</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>174-80</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Does a second resection provide a survival benefit in patients diagnosed with incidental T1b/T2 gallbladder cancer following cholecystectomy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Watson]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Dasari]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Wyatt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[HBP (Oxford)]]></source>
<year>2017</year>
<volume>19</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>104-7</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Surgical strategy for T2 gallbladder cancer according to tumor location]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Surg Oncol]]></source>
<year>2015</year>
<volume>22</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>2779-86</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer an international multicenter study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shindoh]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[De Aretxabala]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Aloia]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Surg]]></source>
<year>2015</year>
<volume>261</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>733-9</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer Results of a retrospective multicenter study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Jeong]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
<name>
<surname><![CDATA[Jang]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
</person-group>
<source><![CDATA[Surgery]]></source>
<year>2017</year>
<volume>162</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>515-24</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Radical lymph node dissection and assessment impact on gallbladder cancer prognosis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[XH]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[YX]]></given-names>
</name>
</person-group>
<source><![CDATA[World J Gastroenterol]]></source>
<year>2013</year>
<volume>19</volume>
<numero>31</numero>
<issue>31</issue>
<page-range>5150-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Surgical treatment for gallbladder cancer - A systematic literature review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sternby Eliard]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lundgren]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cahlin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Scand J Gastroenterol]]></source>
<year>2017</year>
<volume>52</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>505-14</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effects of surgical methods and tumor location on survival and recurrence patterns after curative resection in patients with T2 gallblader cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Jang]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Gut Liver]]></source>
<year>2016</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>140-6</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gani]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Buettner]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Margonis]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
</person-group>
<source><![CDATA[J Surg Oncol]]></source>
<year>2016</year>
<volume>114</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>176-80</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Surgical management of gallbladder cancer simple versus extended cholecystectomy and the role of adjuvant therapy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kasumova]]></surname>
<given-names><![CDATA[GG]]></given-names>
</name>
<name>
<surname><![CDATA[Tabatabaie]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Najarian]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Surg]]></source>
<year>2017</year>
<volume>226</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>625-31</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbladder cancer a multi-institutional analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Amini]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Surg Oncol]]></source>
<year>2016</year>
<volume>23</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>2998-3008</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluation of adjuvant radiation therapy for resected gallbladder carcinoma a multi-institutional experience]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Narang]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Sugar]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Surg Oncol]]></source>
<year>2015</year>
<volume>22</volume>
<numero>Suppl 3</numero>
<issue>Suppl 3</issue>
<page-range>S1100-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
